Skip to main content

Table 1 Detailed information about the participants and the measurements for the cytometries used in the experiments

From: optimalFlow: optimal transport approach to flow cytometry gating and population matching

  Center Final diagnosis Tested sample Coagulant Sex Age Incubation period Flow cytometer
\({\mathcal {C}}^{1}\) 1 HD PB EDTA M 53 30 BD FACSCanto
\({\mathcal {C}}^{2}\) 1 HD PB EDTA M 50 30 BD FACSCanto
\({\mathcal {C}}^{3}\) 1 HD PB EDTA M 61 30 BD FACSCanto
\({\mathcal {C}}^{4}\) 2 HD PB Heparin M 29 30 BD FACSCanto
\({\mathcal {C}}^{5}\) 2 HD PB Heparin M 38 30 BD FACSCanto
\({\mathcal {C}}^{6}\) 2 HD PB Heparin F 27 30 BD FACSCanto
\({\mathcal {C}}^{7}\) 2 HD PB Heparin F NA 30 BD FACSCanto
\({\mathcal {C}}^{8}\) 2 HD PB Heparin M NA 30 BD FACSCanto
\({\mathcal {C}}^{9}\) 2 HD PB Heparin F NA 30 BD FACSCanto
\({\mathcal {C}}^{10}\) 2 HD PB Heparin F NA 30 BD FACSCanto
\({\mathcal {C}}^{11}\) 3 HD PB NA M 34 15 BD FACSCanto
\({\mathcal {C}}^{12}\) 3 HD PB NA F 33 15 BD FACSCanto
\({\mathcal {C}}^{13}\) 3 HD PB NA M 32 15 BD FACSCanto
\({\mathcal {C}}^{14}\) 3 HD PB NA M 33 15 BD FACSCanto
\({\mathcal {C}}^{15}\) 3 HD PB NA F 35 15 BD FACSCanto
\({\mathcal {C}}^{16}\) 3 HD PB EDTA NA Adult 15 BD FACSCanto
\({\mathcal {C}}^{17}\) 3 HD PB EDTA NA Adult 15 BD FACSCanto
\({\mathcal {C}}^{18}\) 3 HD PB EDTA NA Adult 15 BD FACSCanto
\({\mathcal {C}}^{19}\) 3 HD PB EDTA NA Adult 15 BD FACSCanto
\({\mathcal {C}}^{20}\) 3 HD PB EDTA NA Adult 15 BD FACSCanto
\({\mathcal {C}}^{21}\) NA HD NA NA NA NA NA BD FACSCanto
\({\mathcal {C}}^{22}\) 4 MCL PB NA F 82 15 BD FACSCanto
\({\mathcal {C}}^{23}\) 4 MCL PB NA M 70 15 BD FACSCanto
\({\mathcal {C}}^{24}\) 4 FL BM NA M 52 15 BD FACSCanto
\({\mathcal {C}}^{25}\) 4 MCL BM NA M 81 15 BD FACSCanto
\({\mathcal {C}}^{26}\) 4 LPL PB NA M 67 15 BD FACSCanto
\({\mathcal {C}}^{27}\) 1 CLL LN Other F 61 30 BD FACSCanto
\({\mathcal {C}}^{28}\) 1 CLL LN Other F 61 30 BD FACSCanto
\({\mathcal {C}}^{29}\) 1 HD PB EDTA F 27 30 BD FACSCanto
\({\mathcal {C}}^{30}\) 1 HD PB EDTA M 54 30 BD FACSCanto
\({\mathcal {C}}^{31}\) 1 HD PB EDTA M 50 30 BD FACSCanto
\({\mathcal {C}}^{32}\) 1 HD PB EDTA F 36 30 BD FACSCanto
\({\mathcal {C}}^{33}\) 1 HD PB EDTA M 74 30 BD FACSCanto
\({\mathcal {C}}^{34}\) 1 DLBCL Other Other M 65 30 BD FACSCanto
\({\mathcal {C}}^{35}\) 1 HCL BM EDTA M 40 30 BD FACSCanto
\({\mathcal {C}}^{36}\) 2 HD PB Heparin M 38 30 BD FACSCanto
\({\mathcal {C}}^{37}\) 2 HD PB Heparin F 27 30 BD FACSCanto
\({\mathcal {C}}^{38}\) 2 HD PB Heparin M NA 30 BD FACSCanto
\({\mathcal {C}}^{39}\) 2 HD PB Heparin F NA 30 BD FACSCanto
\({\mathcal {C}}^{40}\) 3 HD PB EDTA NA NA 15 BD FACSCanto
  1. Samples come from four international centers labelled as 1–4. Diagnosis abbreviations correspond to: healthy diagnosis, mantle cell lymphoma, follicular lymphoma, lymphoplasmacytic lymphoma, chronic lymphocytic leukemia, diffuse large B-cell lymphoma and hairy cell leukemia. The abbreviations for the type of tested samples correspond to: peripherial blood, bone marrow, lymph node. Coagulant refers to the type of coagulant used for preservation of the sample. The incubation period is measured in minutes